Pfizer Inc

NYSE:PFEUnited States

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.

Contact Information

Headquarters

66 HUDSON BOULEVARD EASTNEW YORK, NY, United States 10001-2192

Phone

212-733-2323

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer

Albert Bourla

Executive Vice President, Chief Financial Officer

David Denton

Executive Vice President, Chief People Experience Officer

Payal Sahni

Executive Vice President, Chief Digital and Technology Officer

Lidia Fonseca

Executive Vice President, Chief Compliance, Quality and Risk Officer

Rady Johnson